TARGETING THE IMMUNOSUPPRESSIVE MICROENVIRONMENT OF PROSTATE CANCER TO ENHANCE THERAPEUTIC EFFICACY OF THE IMMUNE CHECKPOINT INHIBITORS

Icahn School Of Medicine At Mount Sinai, New York NY

Investigators